Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-04-18

Clinical Trial Update: Concordance of the Quotient Attention Deficit Hyperactivity Disorder (ADHD) System Report With Teacher and Parent Assessments for Symptoms of ADHD

View source ↗

Summary

A withdrawn clinical trial assessing how the Quotient ADHD system reports concordance with teacher and parent assessments for ADHD symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: BioBehavioral Diagnostics Company | Conditions: Attention Deficit Hyperactivity Disorder | Status: WITHDRAWN